EUVIMEDEUVIMED entdecken
Crossref

Network Pharmacology, Molecular Docking and Dynamics-Based Strategy to Explore the Potential Mechanism of Melatonin Against Thymoma

Emel Akbaba, Zekeriya Düzgün

Ahi Evran Medical Journal · 29.04.2026 · 10 (1) · 120-132

DOI: 10.46332/aemj.1666706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ahi Evran Medical Journal, online erschienen am 29.04.2026. Verfasst von Emel Akbaba und 1 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Thymic epithelial tumors, although rare neoplasms, are the most common tumors of the anterior mediastinum. They are generally treated with surgery; however, they may also require chemotherapy. Melatonin, known for regulating circadian rhythms, has demonstrated anti-cancer properties However, its effects on thymic epithelial tumors have not yet been investigated.Materials and Methods: Melatonin and thymoma-related proteins (2170 genes) were screened from various databases. Then, protein-protein interaction network of the intersected genes (316 genes) was constructed using STRING database. Cytoscape was utilized to determine hub genes .

Results

KEGG analysis revealed the associated pathways as PI3K-AKT, MAPK, HIF-1, and FOXO. Molecular docking and dy-namics simulations revealed high conformational stability between melatonin and hub genes, notably ESR1 (ER-alpha) and FOS. ESR1 exhibited the lowest MMPBSA binding enthalpy (-100.36 kJ/mol from 100-ns MD simulations), which is distinct from the initial docking scores. Although TP53 showed the lowest docking binding free energy (-11.49 kcal/mol), ESR1 demonstrated superior conformational stability and enthalpic favorability throughout the MD trajectory, suggesting a critical role in modulating estrogen receptor-mediated transcriptional activity. The high conformational stability in ESR1/melatonin complex could modulate the activity of estrogen receptor-α and probably inhibit cancer cell growth and progression through the regulation of PI3K/AKT and MAPK pathways. Additionally, melatonin interactions with p53, SMAD3, MYC, and STAT3 suggest a broader impact on tumor cell regulation and survival pathways.

Conclusion

These findings provide novel insights into the molecular mechanisms underlying melatonin’s anti-cancer effects on thymoma and related cancer types, offering a potential avenue for targeted therapeutic interventions.

Zitieren

APA

Akbaba, E., & Düzgün, Z. (2026). Network Pharmacology, Molecular Docking and Dynamics-Based Strategy to Explore the Potential Mechanism of Melatonin Against Thymoma. Ahi Evran Medical Journal, 10(1), 120-132. https://doi.org/10.46332/aemj.1666706

Vancouver

Akbaba E, Düzgün Z. Network Pharmacology, Molecular Docking and Dynamics-Based Strategy to Explore the Potential Mechanism of Melatonin Against Thymoma. Ahi Evran Medical Journal. 2026;10(1):120-132. doi:10.46332/aemj.1666706

BibTeX
@article{Akbaba2026,
  author = {Akbaba, Emel and Düzgün, Zekeriya},
  title = {Network Pharmacology, Molecular Docking and Dynamics-Based Strategy to Explore the Potential Mechanism of Melatonin Against Thymoma},
  journal = {Ahi Evran Medical Journal},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {120--132},
  doi = {10.46332/aemj.1666706}
}
Kostenlos starten →